This full-day conference offers an exclusive forum for neurotechnology executives and entrepreneurs to interact with investors, technologists, and potential partners who are actively working to grow this new and exciting industry. The schedule of presentations and panel discussions features a host of experts with a wealth of information on the neurotechnology industry and the investment community.

Sessions will cover a range of technologies and market segments in the neuro space, including neuromodulation, neural prostheses, neurodiagnostics, and neurostimulation. Attendees will hear from some of the leading researchers and entrepreneurs developing clinically and commercially promising products such as cochlear implants, stroke rehabilitation devices, implanted pain stimulators, neural-computer interfaces, and advanced brain sensing technologies.

Keynote speaker for the forum is Warren Grill, Ph.D., one of the nation's leading experts in neural stimulation, neural prostheses, computational neuroscience, and neural control. Dr. Grill is the Elmer L. Lindseth Assistant Professor of Biomedical Engineering at Case Western Reserve University and a principal investigator at the Cleveland FES Center. He is a founding member of the International Functional Electrical Stimulation Society and serves on the editorial board of of Neuromodulation, the journal of the International Neuromodulation Society.

A morning panel discussion on the VC outlook for neurotechnology features representatives of some of the leading venture capital firms active in the neuro space. The panelists will discuss critical issues such as the relative strengths and weaknesses of devices and bio/pharma approaches to neurological disorders, the current investment climate in the neuro space, and key factors in obtaining funding for neurotechnology startups.

An afternoon panel discussion on management issues affecting the neurotechnology industry features several entrepreneurs and executives from leading neurotechnology firms. Topics to be covered in this panel include the reimbursement outlook for stimulation devices, developing supportive clinician communities, and partnering opportunities with biotech firms. Neurotech Reports editor and publisher James Cavuoto will serve as moderator for the panel discussions. The forum will also feature presentation from six early-stage neurotechnology firms covering a range of product and technology areas.